Human Anti-LAG3 (clone F7) scFv-Fc Chimera

CAT#: VS-0125-FY4

Anti-LAG3 scFv-Fc is a monoclonal antibody therapy targeting LAG3 (lymphocyte activation gene 3). LAG3 is a transmembrane protein expressed on activated lymphocytes, natural killer cells, and plasmacytoid dendritic cells. Its primary function is to act as an immune inhibitory receptor, negatively regulating cell activation and proliferation to ensure the modulation and control of immune responses. Anti-LAG3 scFv-Fc represents an important direction for the development of novel immunosuppressants, providing new possibilities for cancer therapies.

Gene Expression
Figure 1 IHC staining of human tonsil Figure 2 IHC staining of human cerebral cortex Figure 3 Colon Figure 4 Liver Figure 5 Testis Figure 6 Lymph node Figure 7 RNA cell line category: Cell line enriched (HDLM-2)

Specifications

  • Host Species
  • Human
  • Type
  • Human IgG1, scFv-Fc
  • Species Reactivity
  • Human
  • Clone
  • F7
  • Applications
  • ELISA, Flow Cytometry
  • Related Disease
  • Cancer

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Format
  • Liquid
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Stabilizer
  • No Stabilizers
  • Sterility
  • 0.2 μM filtered
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
  • Shipping
  • Ice packs

Applications

  • Application Notes
  • The anti-LAG3 scFv-Fc combines the features of a single-chain variable fragment (scFv) and the Fc region, exhibiting strong targeting ability and sustained biological activity. By targeting LAG3, this antibody can reactivate tumor-infiltrating lymphocytes, promoting the immune system's recognition and attack on tumor cells. This therapy holds promise for improving treatment outcomes in patients who do not respond to current immune checkpoint therapies and may become an important complement in anti-tumor immunotherapy.

Target

  • Alternative Names
  • CD223
  • Sequence Similarities
  • Belongs to the LAG3 family.
  • Cellular Localization
  • Secreted
  • Post Translation Modifications
  • Glycosylation at Asn188, Asn250, Asn256, and Asn343
    Modification sites at PhosphoSitePlus
    Glycosylation from GlyGen 4 sites
  • Function
  • Lymphocyte activation gene 3 protein: Inhibitory receptor on antigen activated T-cells.
    Delivers inhibitory signals upon binding to ligands, such as FGL1 (By similarity).
    FGL1 constitutes a major ligand of LAG3 and is responsible for LAG3 T-cell inhibitory function (By similarity).
    Following TCR engagement, LAG3 associates with CD3-TCR in the immunological synapse and directly inhibits T-cell activation (By similarity).
    May inhibit antigen-specific T-cell activation in synergy with PDCD1/PD-1, possibly by acting as a coreceptor for PDCD1/PD-1 (By similarity).
    Negatively regulates the proliferation, activation, effector function and homeostasis of both CD8(+) and CD4(+) T-cells.
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for VS-0125-FY4. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Secondary Antibody

Isotype Control

See other products for "Clone F7"

See other products for "LAG3"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
NEUT-1675CQ Recombinant Mouse Anti-LAG3 Antibody (11E3) WB, Neut, ELISA, IF, IHC, IP IgG1
NEUT-1676CQ Recombinant Rat Anti-Lag3 Antibody (C9B7W) ELISA, FuncS, FC, IP, Neut IgG1, κ
CAT Product Name Application Type
VS-0325-FY9 Human Anti-LAG3 (clone SRP1449-B03) scFv-Fc Chimera ELISA, FC Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC460 Recombinant Anti-LAG3 Vesicular Antibody, EV Displayed (VS-0425-YC460) Block, ELISA, FC, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare